Latest / Glaucoma, Vision & Longevity: Supplements & Science
The 2024–2025 Pipeline for IOP-Independent Neuroprotection in Glaucoma
This audio article is from VisualFieldTest.com.
Read the full article here: https://visualfieldtest.com/en/the-2024-2025-pipeline-for-iop-independent-neuroprotection-in-glaucoma
Test your visual field online: https://visualfieldtest.com
Excerpt:
Introduction Glaucoma is a common eye disease that damages retinal ganglion cells (RGCs) – the nerve cells that carry visual signals from the eye to the brain – leading to irreversible vision loss. Most treatments focus on lowering eye pressure (intraocular pressure or IOP), which indeed slows damage in many patients (). However, a large fraction of…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.